Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin

European Journal of Immunology

Volumn 28, Issue 9, 1998, Pages 2726-2737

  Lee, Ren Shiang ^a   Tartour, Eric ^a   Van Bruggen, Pierre Der ^b   Vantomme, Valérie ^b   Joyeux, Isabelle ^a   Goud, Bruno ^c   Fridman, Wolf Herman ^a   Johannes, Ludger ^c  

^a INSTITUT CURIE   (France)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^c CNRS   (France)

Author keywords

Antigen presentation; MHC class I; Shiga toxin; Vaccine vector

Indexed keywords

BREFELDIN A; EPITOPE; HYBRID PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PARAFORMALDEHYDE; RECOMBINANT PROTEIN; SHIGA TOXIN; TUMOR ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; DENDRITIC CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYMPHOBLASTOID CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; SHIGELLA DYSENTERIAE; VIRUS CELL TRANSFORMATION;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; BACTERIAL TOXINS; CYTOTOXINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; RECOMBINANT PROTEINS; SHIGA TOXINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES;

EID: 0031692642     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199809)28:09<2726::AID-IMMU2726>3.0.CO;2-W     Document Type: Article

References (60)

1. Heemels, M. T. and Ploegh, H., Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 1995. 64: 463-491.
2. Pieters, J., MHC class II restricted antigen presentation. Curr. Opin. Immunol. 1997. 9: 89-96.
3. Kurts, C., Heath, W. R., Carbone, F. R., Allison, J., Miller, J. F. and Kosaka, H., Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 1996. 184: 923-930.
4. Huang, A. Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D. and Levitsky, H., Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994. 264: 961-965.
5. Rock, K. L., A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 1996. 17: 131-137.
6. Watts, C., Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 1997. 15: 821-850.
7. Sabzevari, H. and Reisfeld, R. A., Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice. Cancer Res. 1993. 53: 4933-4937.
8. Stevenson, P. G., Hawke, S. and Bangham, C. R., Protection against influenza virus encephalitis by adoptive lymphocyte transfer. Virology 1997. 232: 158-166.
9. Feltkamp, M. C., Vreugdenhil, G. R., Vierboom, M. P., Ras, E., van der Burg, S. H., ter Schegget, J., Melief, C. J. and Kast, M. W., Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors. Eur. J. Immunol. 1995. 25: 2638-2642.
10. Gao, X. M., Tite, J. P., Lipscombe, M., Rowland-Jones, S., Ferguson, D. J. and McMichael, A. J., Recombinant Salmonella typhimurium strains that invade nonphagocytic cells are resistant to recognition by antigen-specific cytotoxic T lymphocytes. Infect. Immun. 1992. 60: 3780-3789.
11. Pan, Z. K., Ikonomidis, G., Pardoll, D. and Paterson, Y., Regression of established tumors in mice mediated by the oral administration of a recombinant Listeria monocytogenes vaccine. Cancer Res. 1995. 55: 4776-4779.
12. Tsang, K. Y., Zaremba, S., Nieroda, C. A., Zhu, M. Z., Hamilton, J. M. and Schlom, J., Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J. Natl. Cancer. Inst. 1995. 87: 982-990.
13. Kavanaugh, D. Y. and Carbone, D. P., Immunologic dysfunction in cancer. Hematol. Oncol. Clin. North Am. 1996. 10: 927-951.
14. Redfield, R. R., Wright, D. C., James, W. D., Jones, T. S., Brown, C. and Burke, D. S., Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N. Engl. J. Med. 1987. 316: 673-676.
15. Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B. and Rock, K. L., Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA 1993. 90: 4942-4946.
16. Harding, C. V. and Song, R., Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 1994. 153: 4925-4933.
17. Nair, S., Zhou, F., Reddy, R., Huang, L. and Rouse, B. T., Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. J. Exp. Med. 1992. 175: 609-612.
18. Ke, Y., Li, Y. and Kapp, J. A., Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses. Eur. J. Immunol. 1995. 25: 549-553.
19. Lipford, G. B., Bauer, M., Blank, C., Reiter, R., Wagner, H. and Heeg, K., CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur. J. Immunol. 1997. 27: 2340-2344.
20. Reis e Sousa, C. and Germain, R. N., Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 1995. 182: 841-851.
21. Darji, A., Chakraborty, T., Wehland, J. and Weiss, S., TAP-dependent major histocompatibility complex class I presentation of soluble proteins using listeriolysin. Eur. J. Immunol. 1997. 27: 1353-1359.
22. Johannes, L. and Goud, B., Surfing on a retrograde wave: How does Shiga toxin reach the endoplasmic reticulum. Trends Cell Biol. 1998. 8: 158-162.
23. Sandvig, K. and van Deurs, B., Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol. Rev. 1996. 76: 949-966.
24. Johannes, L., Tenza, D., Antony, C. and Goud, B., Retrograde transport of KDEL-bearing B-fragment of Shiga toxin. J. Biol. Chem. 1997. 272: 19554-19561.
25. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A. and Boon, T. A., Gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991. 254: 1643-1647.
26. Perez, F., Joliot, A., Block-Gallego, E., Zahraoui, A., Triller, A. and Prochiantz, A., Antennapedia homeobox as a signal for the cellular internalization and nuclear addressing of a small exogenous peptide. J. Cell Sci. 1992. 102: 717-722.
27. Schutze-Redelmeier, M. P., Gournier, H., Garcia-Pons, F., Moussa, M., Joliot, A. H., Volovitch, M., Prochiantz, A. and Lemonnier, F. A., Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo. J. Immunol. 1996. 157: 650-655.
28. Sandvig, K., Ryd, M., Garred, O., Schweda, E., Holm, P. K. and van Deurs, B., Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP. J. Cell Biol. 1994. 126: 53-64.
29. Pudymaitis, A. and Lingwood, C. A., Susceptibility to verotoxin as a function of the cell cycle. J. Cell Physiol. 1992. 150: 632-639.
30. Cohen, A., Madrid-Marina, V., Estrov, Z., Freedman, M. H., Lingwood, C. A. and Dosch, H. M., Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease. Jnt. Immunol. 1990. 2: 1-8.
31. Donnelly, J. J., Ulmer, J. B., Hawe, L. A., Friedman, A., Shi, X. P., Leander, K. R., Shiver, J. W., Oliff, A. I., Martinez, D., Montgomery, D. and Liu, M. A., Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin. Proc. Natl. Acad. Sci. USA 1993. 90: 3530-3534.
32. Liu, M. A., The immunologist's grail: vaccines that generates cellular immunity. Proc. Natl. Acad. Sci. USA 1997. 94: 10496-10498.
33. Goletz, T. J., Klimpel, K. R., Arora, N., Leppla, S. H., Keith, J. M. and Berzofsky, J. A., Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein. Proc. Natl. Acad. Sci. USA 1997. 94: 12059-12064.
34. Saron, M. F., Fayolle, C., Sebo, P., Ladant, D., Ullmann, A. and Leclerc, C., Anti-viral conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus. Proc. Natl. Acad. Sci. USA 1997. 94: 3314-3319.
35. Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J. and Harding, C. V., Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993. 360: 359-362.
36. Schirmbeck, R., Melber, K. and Reimann, J., Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur. J. Immunol. 1995. 25: 1063-1070.
37. Speidel, K., Osen, W., Faath, S., Hilgert, I., Obst, R., Braspenning, J., Momburg, F., Hammerling, G. J. and Rammensee, H. G., Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses. Eur. J. Immunol. 1997. 27: 2391-2399.
38. Rock, K. L., Rothstein, L., Gamble, S. and Fleischacker, C., Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J. Immunol. 1993. 150: 438-446.
39. Shen, Z., Reznikoff, G., Dranoff, G. and Rock, K. L., Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 1997. 158: 2723-2730.
40. Bachmann, M. F., Lutz, M. B., Layton, G. T., Harris, S. J., Fehr, T., Rescigno, M. and Ricciardi-Castagnoli, P., Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes. Eur. J. Immunol. 1996. 26: 2595-2600.
41. Brossart, P. and Bevan, M. J., Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 1997. 90: 1594-1599.
42. Norbury, C. C., Hewlett, L. J., Prescott, A. R., Shastri, N. and Watts, C., Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 1995. 3: 783-791.
43. Layton, G. T., Harris, S. J., Myhan, J., West, D., Gotch, F., Hill-Perkins, M., Cole, J. S., Meyers, N., Woodrow, S., French, T. J., Adams, S. E. and Kingsman, A. J., Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles. Immunology 1996. 87: 171-178.
44. Griffiths, J. C., Harris, S. J., Layton, G. T., Berrie, E. L., French, T. J., Burns, N. R., Adams, S. E. and Kingsman, A. J., Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion. J. Virol. 1993. 67: 3191-3198.
45. Suto, R. and Srivastava, P. K., A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995. 269: 1585-1588.
46. Ke, Y. and Kapp, J. A., Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake. J. Exp. Med. 1996. 184: 1179-1184.
47. Barnaba, V., Franco, A., Alberti, A., Benvenuto, R. and Balsano, F., Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature 1990. 345: 258-260.
48. Liu, T., Zhou, X., Orvell, C., Lederer, E., Ljunggren, H. G. and Jondal, M., Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. J. Immunol. 1995. 154: 3147-3155.
49. Ulmer, J. B., Donnelly, J. J. and Liu, M. A., Presentation of an exogenous antigen by major histocompatibility complex class I molecules. Eur. J. Immunol. 1994. 24: 1590-1596.
50. Chowdhury, M. G., Maeda, K., Yasutomo, K., Maekawa, Y., Furukawa, A., Azuma, M., Nagasawa, H. and Himeno, K., Antigen-specific B cells are required for the secondary response of T cells but not for their priming. Eur. J. Immunol. 1996. 26: 1628-1633.
51. Guery, J. C., Ria, F., Galbiati, F. and Adorini, L., Normal B cells fail to secrete interleukin-12. Eur. J. Immunol. 1997. 27: 1632-1639.
52. Saoudi, A., Simmonds, S., Huitinga, I. and Mason, D., Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J. Exp. Med. 1995. 182: 335-344.
53. Marchand, M., Weynants, P., Rankin, E. et al., Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer 1995. 63: 883-885.
54. Ortiz-Navarrete, V. and Hämmerling, G. J., Surface appearance and instability of empty H-2 class I molecules under physiological conditions. Proc. Natl. Acad. Sci. USA 1991. 88: 3594-3597.
55. Deres, K., Schild, H., Wiesmuller, K. H., Jung, G. and Rammensee, H. G., In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 1989. 342: 561-564.
56. Minev, B. R., McFarland, B. J., Spiess, P. J., Rosenberg, S. A. and Restifo, N. P., Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice. Cancer Res. 1994. 54: 4155-4161.
57. Falo, L. D. Jr., Kovacsovics-Bankowski, M., Thompson, K. and Rock, K. L., Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. N. Med. 1995. 1: 649-653.
58. Sedlik, C., Saron, M., Sarraseca, J., Casal, I. and Leclerc, C., Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. Proc. Natl. Acad. Sci. USA 1997. 94: 7503-7508.
59. Mangeney, M., Lingwood, C. A., Taga, S., Caillou, B., Tursz, T. and Wiels, J., Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res. 1993. 53: 5314-5319.
60. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994. 179: 1109-1118.